Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders

Journal of Pediatrics

Volumn 134, Issue 5, 1999, Pages 607-613

  Connolly, Anne M ^a,b,c   Chez, Michael G ^a,b   Pestronk, Alan ^a,b   Arnold, Susan T ^a,b   Mehta, Shobhna ^a,b   Deul, Ruthmary K ^a,b  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BRAIN ANTIBODY;

ARTICLE; AUTISM; AUTOIMMUNITY; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INTELLECT; LANDAU KLEFFNER SYNDROME; LANGUAGE DEVELOPMENT; MALE; PRIORITY JOURNAL; SOCIAL EVOLUTION;

EID: 0033510928     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70248-9     Document Type: Article

References (43)

1. 1. Happe F, Frith U. The neuropsychology of autism. Brain 1996;119:1377-400.
2. 2. Shaffer D, Campbell M. Disorders usually diagnosed in infancy, childhood or adolescence. In: First MB, editor. Diagnostic and statistical manual of mental disorders IV. Washington (DC): American Psychiatric Association; 1994. p. 67.
3. 3. Folstein D, Rutter M. Genetic influences and infantile autism. Nature 1977;265:726-8.
4. 4. International Molecular Genetic Study of Autism Consortium. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. Hum Mol Genet 1998;7:571-8.
5. 5. Nordin V, Gillberg C. Autism spectrum disorders in children with physical or mental disability or both. I. Clinical and epidemiological aspects. Dev Med Child Neurol 1996;38:297-313.
6. 6. DeLong G, Bear B, Brown F. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 1981;38:191-4.
7. 7. Gupta S, Aggarwal S, Heads C. Brief report: dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord 1996;26:439-52.
8. 8. Stubbs EG, Crawford ML, Burger DR, Vanderbark AA. Depressed lymphocyte responsiveness in autistic children. J Autism Child Schizophr 1977; 7:49-55.
9. 9. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun 1993;7:97-103.
10. 10. Singh VK, Cheng JF. Immunoreactive S100 proteins of blood immunocytes and brain cells. J Neuroimmunol 1996;64:135-9.
11. 11. Warren RP, Margaretten NC, Pace NC, Foster A. Immune abnormalities in patients with autism. J Autism Dev Disord 1986;16:189-97.
12. 12. Warren RP, Foster A, Margaretten NC. Reduced natural killer cell activity in autism. J Am Acad Child Adolesc Psychiatry 1987;26:333-5.
13. 13. Warren RP, Cole P, Odell JD, Pingree CB, Warren WL, White E, et al. Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry 1990;29:873-7.
14. 14. Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, et al. Deficiency of suppressor-inducer (CD4+CD45RA+) T cells in autism. Immunol Invest 1990;19:245-51.
15. 15. Warren RP, Burger RA, Odell D, Torres AR, Warren WL. Decreased plasma concentrations of the C4B complement protein in autism. Arch Pediatr Adolesc Med 1994;148:180-3.
16. 16. Warren RP, Yonk J, Burger RW, Odell D, Warren WL. DR-positive T cells in autism: association with decreased plasma levels or the complement C4B protein. Neuropsychobiology 1995;31:53-7.
17. 17. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Torres AR. Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder? J Am Acad Child Adolesc Psychiatry 1995;34:1009-14.
18. 18. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW, et al. Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J Neuroimmunol 1996;67:97-102.
19. 19. Singh VK, Fudenberg HH, Emerson D, Coleman M. Immunodiagnosis and immunotherapy in autistic children. Ann N Y Acad Sci 1988;540:602-4.
20. 20. Todd R. Pervasive developmental disorders and immunological tolerance. Pyschiatr Dev 1986;2:147-65.
21. 21. Todd RD, Hickok JM, Anderson GM, Cohen DJ. Antibrain antibodies in infantile autism. Biol Psychol 1988;23: 644-7.
22. 22. Gupta S, Aggarwal S, Rashanravan B, Lee T. Th1- and Th2-like cytokines in CD4(+) and CD8(+) T cells in autism. J Neuroimmunol 1998;85:106-9.
23. 23. Plioplys AV. Intravenous immunoglobulin treatment of children with autism. J Child Neurol 1998;13:79-82.
24. 24. Gupta S, Rimland B, Shilling PD. Pentoxifylline: brief review and rationale tor its possible use in the treatment of autism. J Child Neurol 1996; 11:501-4.
25. 25. Reap EA, Lawson JW. Stimulation of the immune response by dimethylglycine, a nontoxic metabolite. J Lab Clin Med 1990;115:481-6.
26. 26. van Cent T, Heijnen CJ, Treffers PD. Autism and the immune system. J Child Psychol Psychiatry 1997;38: 337-49.
27. 27. Delgiudice-asch G, Hollander E. Altered immune function in autism. CNS Spect 1997;2:61-7.
28. 28. Appleton RE. The Landau-Kleffner syndrome. Arch Dis Child 1995;72: 386-7.
29. 29. Echenne B, Cheminal R, Rivier F, Negre C, Touchon J, Billiard M. Epileptic electroencephalographic abnormalities and developmental dysphasias: a study of 32 patients. Brain Dev 1992;14:216-25.
30. 30. Landau WM. Landau-Kleffner syndrome. An eponymic badge of ignorance. Arch Neurol 1992;49:353.
31. 31. Lerman P, Lerman-Sagie T, Kivity S. Effect of early corticosteroid therapy for Landau-Kleffner syndrome. Dev Med Child Neurol 1991;33:257-60.
32. 32. Paquier PF, Van Dongen HR, Loonen CB. The Landau-Kleffner syndrome or 'acquired aphasia with convulsive disorder'. Long-term follow-up of six children and a review of the recent literature. Arch Neurol 1992;49:354-9.
33. 33. Shafrir Y, Prensky AL. Acquired epileptiform opercular syndrome: a second case report, review of the literature, and comparison to the Landau-Kleffner syndrome. Epilepsia 1995;36: 1050-7.
34. 34. Soprano AM, Garcia EF, Caraballo R, Fejerman N. Acquired epileptic aphasia: neuropsychologic lollow-up of 12 patients. Pediatr Neurol 1994; 11:230-5.
35. 35. Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder. Neurology 1957;7:523-30.
36. 36. Mantovani JF, Landau WM. Acquired aphasia with convulsive disorder: course and prognosis. Neurology 1980; 30:524-9.
37. 37. Rapin I. Acquired aphasia in children. J Child Neurol 1995;10:267-70.
38. 38. Marien P, Saerens J, Verslegers W, Borggreve F, De Deyn PP. Some controversies about type and nature of aphasic symptomatology in Landau-Kleffner's syndrome: a case study. Acta Neurol Belg 1993;93:183-203.
39. 39. Fayad MN, Choueiri R, Mikati M. Landau-Kleffner syndrome - consistent response to repeated intravenous gamma-globulin doses: a case report. Epilepsia 1997;38:489-94.
40. 40. Nevsimalova S, Tauberova A, Doutlik S, Kucera V, Dlouha O. A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome? Brain Dev 1992;14:342-5.
41. 41. Aarden LA, deGroot ER, Feltkamp TEW. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 1975;254: 505-15.
42. 42. Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, et al. Antinuclear antibodies in children with chronic nonspecific complaints. Autoimmunity 1997;25:243-50.
43. 43. Perniola T, Margari L, Buttiglione M, Andreula C, Simone IL, Santostasi R. A case of Landau-Kleffner syndrome secondaty to inflammatory demyelinating disease. Epilepsia 1993;34:551-6.